Physician

Chelle P Wilhelm, M.D.

According to 2025 Medicare claims, Chelle Wilhelm, M.D. (NPI: 1154529709) practices allergy/immunology in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (NPI: 1902882251; TIN: 640502151) and primary practice location at 39216-4829.

Wilhelm's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 205 traditional Medicare patients, billed 18,376 HCPCS/CPT codes, and received $484,382 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,333 prescription claims across 180 beneficiaries totaling $442,949 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 180 claims. Open Payments data shows 61 records totaling $13,423. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,387 to $484,382. Similarly, Part D prescription costs have risen steadily, from $21,204 to $442,949. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $431 to $4,450.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	38	107	$4,387
2016	135	366	$17,399
2017	155	1,598	$24,384
2018	223	4,114	$43,910
2019	246	5,632	$83,523
2020	234	9,219	$190,933
2021	210	10,342	$201,343
2022	190	12,071	$264,293
2023	187	13,663	$352,068
2024	205	18,376	$484,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	43	221	$21,204
2016	70	331	$48,669
2017	107	453	$76,132
2018	148	681	$42,985
2019	197	1,196	$102,968
2020	208	1,143	$286,110
2021	174	884	$391,983
2022	194	1,066	$402,697
2023	188	1,200	$494,706
2024	180	1,333	$442,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$146
2017	N/R	N/R	N/R
2018	N/R	66	$62,174
2019	N/R	151	$172,583
2020	N/R	113	$210,387
2021	N/R	141	$219,421
2022	N/R	189	$277,246
2023	N/R	230	$352,970
2024	N/R	180	$315,392

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	37	37	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	221	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	34	36	$58
94010	Test to measure expiratory airflow and volume	54	67	$18
95165	Professional service for preparation and provision of 1 or more antigens	59	1,975	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	14	392	$113,240
Dupixent Pen	Dupilumab	22	602	$83,328
Xolair	Omalizumab	16	448	$55,398
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	2,370	$49,941
Breo Ellipta	Fluticasone/Vilanterol	63	2,130	$26,759

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	23	$149,536
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	15	$82,662
J1576	Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	11	$43,918
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	14	$34,891
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	50	$3,601

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$13,423	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chelle P. Wilhelm, M.D.?

Tedicare shows public-source Medicare data for Chelle P. Wilhelm, M.D. (NPI 1154529709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chelle P. Wilhelm, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chelle P. Wilhelm, M.D.?

Chelle P. Wilhelm, M.D. is linked to MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (billing NPI 1902882251) in the available physician profile data.

Does Chelle P. Wilhelm, M.D. have Open Payments data?

Chelle P. Wilhelm, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.